MMC
60
-2
HSIC
56
3
PPL
60
-7
APD
42
-2
MRK
53
3
EXC
50
-4
D
55
-6
LH
55
2
CMCSA
52
6
HPE
53
2
AIZ
71
-2
FOX
39
2
LYB
44
-2
UHS
58
4
EIX
69
-5
SE
65
4
VZ
45
-2
EQT
44
2
ES
55
-5
HBI
59
-2
MMC
60
-2
HSIC
56
3
PPL
60
-7
APD
42
-2
MRK
53
3
EXC
50
-4
D
55
-6
LH
55
2
CMCSA
52
6
HPE
53
2
AIZ
71
-2
FOX
39
2
LYB
44
-2
UHS
58
4
EIX
69
-5
SE
65
4
VZ
45
-2
EQT
44
2
ES
55
-5
HBI
59
-2
Financhill
Back

Beam Therapeutics Quote, Financials, Valuation and Earnings

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33

BEAM
Beam Therapeutics

Last Price:
26.02
Seasonality Move:
33.43%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

Beam Therapeutics Price Quote

$26.02
-0.05 (2%)
(Updated: September 20, 2024 at 3:30 AM ET)

Beam Therapeutics Key Stats

Sell
33
Beam Therapeutics (BEAM) is a Sell
Day range:
$25.87 - $26.67
52-week range:
$16.95 - $49.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.86
P/B ratio:
2.46%
Volume:
558.6K
Avg. volume:
654.9K
1-year change:
6.41%
Market cap:
$2.1B
Revenue:
$377.7M
EPS:
$-1.81

How Much Does Beam Therapeutics Make?

Is Beam Therapeutics Growing As A Company?

  • What Is Beam Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.41%
  • What Is Beam Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Beam Therapeutics Stock Price Performance

What Is Beam Therapeutics 52-Week High & Low?

Beam Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Beam Therapeutics?

  • How Much Debt Does Beam Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Beam Therapeutics Have?
    Cash and short term investments quarterly total is $1B
  • What Is Beam Therapeutics’s Book Value Per Share?
    Book value per share is 10.37

Is Beam Therapeutics Cash Flow Positive?

  • What Is BEAM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$137.5M
  • What Is Beam Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $73.5M
  • What Is Beam Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $121.9M

Beam Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    BEAM return on invested capital is -16.48%
  • What Is Beam Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -10.63%
  • What Is BEAM Return On Equity?
    ROE is a measure of profitability and is -16.48%

Beam Therapeutics Earnings Date & Stock Price

Beam Therapeutics Competitors

  • Who Are Beam Therapeutics's Competitors?
    Below is a list of companies who compete with Beam Therapeutics or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Intellia Therapeutics Inc (NTLA)
    • Xtant Medical Holdings Inc (XTNT)

Beam Therapeutics Dividend Yield

Beam Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0.73%
Revenue: -41.48% -9.77%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 50.36
Upside from Last Price: 93.16%

Major Shareholders

  • How many BEAM shares are owned by institutional investors?
    114.3M BEAM shares are owned by institutional investors
  • How many BEAM shares are owned by insiders?
    1.5M BEAM shares are owned by insiders